Mesalamine (5-ASA) Induced Myocarditis: A Case Report

INTRODUCTION Inflammatory bowel disease (IBD) is a chronic disorder that presents with intermittent episodes of exacerbation and is classified into Crohn's disease (CD) and Ulcerative colitis (UC). Ulcerative colitis (UC) is a chronic inflammatory condition of unclear etiology affecting the large bowel, most commonly the rectum, and extending proximally continuously. Crohn's disease (CD) can cause inflammation anywhere from the mouth to the anus in the gastrointestinal tract. Mesalamine, chemically known as 5-aminosalicylic acid (5-ASA), belongs to the group of drugs known as amino salicylates. It is typically prescribed as first-line medical therapy in treating UC [1-3]. The precise mechanism of its action is currently not well understood.